Elevance Health (ELV) Competitors

$394.41 -0.28 (-0.07%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$394.60 +0.19 (+0.05%)

As of 05/22/2026 05:05 PM Eastern

ELV vs. CNC, MOH, UNH, CI, and HUM

Should you buy Elevance Health stock or one of its competitors? MarketBeat compares Elevance Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Elevance Health include Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Cigna Group (CI), and Humana (HUM). These companies are all part of the "managed health care" industry.

How does Elevance Health compare to Centene?

Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centene	$198.10B	0.15	-$6.67B	-$13.14	N/A
Elevance Health	$199.13B	0.43	$5.66B	$23.51	16.78

Centene presently has a consensus price target of $56.94, suggesting a potential downside of 3.73%. Elevance Health has a consensus price target of $399.32, suggesting a potential upside of 1.24%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts plainly believe Elevance Health is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centene	2 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.37
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61

Centene has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market. Comparatively, Elevance Health has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market.

In the previous week, Elevance Health had 6 more articles in the media than Centene. MarketBeat recorded 10 mentions for Elevance Health and 4 mentions for Centene. Elevance Health's average media sentiment score of 1.26 beat Centene's score of 0.40 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Centene	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Elevance Health	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elevance Health has a net margin of 2.62% compared to Centene's net margin of -3.25%. Elevance Health's return on equity of 15.58% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centene	-3.25%	5.57%	1.54%
Elevance Health	2.62%	15.58%	5.57%

93.6% of Centene shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.4% of Centene shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Elevance Health beats Centene on 13 of the 17 factors compared between the two stocks.

How does Elevance Health compare to Molina Healthcare?

Molina Healthcare (NYSE:MOH) and Elevance Health (NYSE:ELV) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Molina Healthcare has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market.

Molina Healthcare currently has a consensus price target of $176.00, indicating a potential downside of 4.39%. Elevance Health has a consensus price target of $399.32, indicating a potential upside of 1.24%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts clearly believe Elevance Health is more favorable than Molina Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Molina Healthcare	2 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.06
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61

98.5% of Molina Healthcare shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 1.4% of Molina Healthcare shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Elevance Health has higher revenue and earnings than Molina Healthcare. Elevance Health is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Molina Healthcare	$45.08B	0.21	$472M	$3.38	54.46
Elevance Health	$199.13B	0.43	$5.66B	$23.51	16.78

In the previous week, Elevance Health had 7 more articles in the media than Molina Healthcare. MarketBeat recorded 10 mentions for Elevance Health and 3 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.46 beat Elevance Health's score of 1.26 indicating that Molina Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Molina Healthcare	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elevance Health	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elevance Health has a net margin of 2.62% compared to Molina Healthcare's net margin of 0.42%. Elevance Health's return on equity of 15.58% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Molina Healthcare	0.42%	8.76%	2.32%
Elevance Health	2.62%	15.58%	5.57%

Summary

Elevance Health beats Molina Healthcare on 11 of the 16 factors compared between the two stocks.

How does Elevance Health compare to UnitedHealth Group?

Elevance Health (NYSE:ELV) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. UnitedHealth Group pays an annual dividend of $8.84 per share and has a dividend yield of 2.3%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. UnitedHealth Group pays out 66.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years and UnitedHealth Group has increased its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

UnitedHealth Group has higher revenue and earnings than Elevance Health. Elevance Health is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.43	$5.66B	$23.51	16.78
UnitedHealth Group	$449.71B	0.78	$12.06B	$13.24	29.34

Elevance Health has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 0.3% of UnitedHealth Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Elevance Health currently has a consensus target price of $399.32, suggesting a potential upside of 1.24%. UnitedHealth Group has a consensus target price of $387.57, suggesting a potential downside of 0.22%. Given Elevance Health's higher probable upside, equities research analysts clearly believe Elevance Health is more favorable than UnitedHealth Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
UnitedHealth Group	1 Sell rating(s)	6 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.74

In the previous week, UnitedHealth Group had 78 more articles in the media than Elevance Health. MarketBeat recorded 88 mentions for UnitedHealth Group and 10 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.26 beat UnitedHealth Group's score of 1.03 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UnitedHealth Group	60 Very Positive mention(s)	4 Positive mention(s)	12 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

UnitedHealth Group has a net margin of 2.68% compared to Elevance Health's net margin of 2.62%. Elevance Health's return on equity of 15.58% beat UnitedHealth Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
UnitedHealth Group	2.68%	14.65%	4.77%

Summary

UnitedHealth Group beats Elevance Health on 11 of the 20 factors compared between the two stocks.

How does Elevance Health compare to Cigna Group?

Elevance Health (NYSE:ELV) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

Elevance Health currently has a consensus price target of $399.32, indicating a potential upside of 1.24%. Cigna Group has a consensus price target of $339.80, indicating a potential upside of 18.79%. Given Cigna Group's stronger consensus rating and higher possible upside, analysts clearly believe Cigna Group is more favorable than Elevance Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
Cigna Group	0 Sell rating(s)	5 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.81

Elevance Health has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market.

In the previous week, Cigna Group had 9 more articles in the media than Elevance Health. MarketBeat recorded 19 mentions for Cigna Group and 10 mentions for Elevance Health. Cigna Group's average media sentiment score of 1.40 beat Elevance Health's score of 1.26 indicating that Cigna Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cigna Group	17 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years and Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Elevance Health has a net margin of 2.62% compared to Cigna Group's net margin of 2.26%. Cigna Group's return on equity of 19.75% beat Elevance Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Cigna Group	2.26%	19.75%	5.30%

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 87.0% of Cigna Group shares are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 0.6% of Cigna Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Cigna Group has higher revenue and earnings than Elevance Health. Cigna Group is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.43	$5.66B	$23.51	16.78
Cigna Group	$274.90B	0.28	$5.96B	$23.59	12.13

Summary

Cigna Group beats Elevance Health on 13 of the 20 factors compared between the two stocks.

How does Elevance Health compare to Humana?

Elevance Health (NYSE:ELV) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Humana had 6 more articles in the media than Elevance Health. MarketBeat recorded 16 mentions for Humana and 10 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.26 beat Humana's score of 1.09 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Humana	12 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Elevance Health has a net margin of 2.62% compared to Humana's net margin of 0.82%. Elevance Health's return on equity of 15.58% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Humana	0.82%	10.45%	3.75%

Elevance Health has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market. Comparatively, Humana has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.43	$5.66B	$23.51	16.78
Humana	$129.66B	0.28	$1.19B	$9.35	32.92

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 0.2% of Humana shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.2%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Humana pays out 37.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Elevance Health currently has a consensus price target of $399.32, indicating a potential upside of 1.24%. Humana has a consensus price target of $263.35, indicating a potential downside of 14.44%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts plainly believe Elevance Health is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
Humana	4 Sell rating(s)	15 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.18

Summary

Elevance Health beats Humana on 15 of the 19 factors compared between the two stocks.

Get Elevance Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELV vs. The Competition

Export

Metric	Elevance Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$85.65B	$8.38B	$6.43B	$23.19B
Dividend Yield	1.74%	2.98%	2.76%	4.10%
P/E Ratio	16.78	21.27	21.01	30.65
Price / Sales	0.43	24.29	580.16	14.65
Price / Cash	10.50	86.20	43.49	25.12
Price / Book	1.94	5.84	10.36	4.74
Net Income	$5.66B	$183.47M	$3.57B	$1.07B
7 Day Performance	0.27%	65.57%	6.00%	1.45%
1 Month Performance	14.44%	49.96%	3.51%	1.58%
1 Year Performance	5.93%	4.53%	34.12%	28.44%

Elevance Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELV Elevance Health	4.3748 of 5 stars	$394.41 -0.1%	$399.32 +1.2%	+5.9%	$85.65B	$199.13B	16.78	97,100	Positive News Analyst Forecast
CNC Centene	2.2941 of 5 stars	$58.18 -0.2%	$53.82 -7.5%	+4.8%	$28.73B	$194.78B	N/A	61,100	Analyst Forecast
MOH Molina Healthcare	2.2776 of 5 stars	$184.94 0.0%	$174.53 -5.6%	-39.6%	$9.64B	$45.43B	54.72	19,000	Positive News Analyst Forecast
UNH UnitedHealth Group	4.0726 of 5 stars	$390.44 -0.9%	$378.88 -3.0%	+31.5%	$354.57B	$447.57B	29.49	390,000	Positive News Analyst Forecast
CI Cigna Group	4.9449 of 5 stars	$286.14 +0.3%	$338.35 +18.2%	-9.6%	$75.69B	$274.90B	12.13	67,700	Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ELV) was last updated on 5/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Elevance Health (ELV) Competitors

ELV vs. CNC, MOH, UNH, CI, and HUM

How does Elevance Health compare to Centene?

Summary

How does Elevance Health compare to Molina Healthcare?

Summary

How does Elevance Health compare to UnitedHealth Group?

Summary

How does Elevance Health compare to Cigna Group?

Summary

How does Elevance Health compare to Humana?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELV vs. The Competition

Elevance Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Elevance Health (ELV) Competitors

ELV vs. CNC, MOH, UNH, CI, and HUM

How does Elevance Health compare to Centene?

Which has higher valuation and earnings, CNC or ELV?

Do analysts recommend CNC or ELV?

Which has more volatility and risk, CNC or ELV?

Does the media prefer CNC or ELV?

Is CNC or ELV more profitable?

Do institutionals & insiders hold more shares of CNC or ELV?

Summary

How does Elevance Health compare to Molina Healthcare?

Which has more risk and volatility, MOH or ELV?

Do analysts rate MOH or ELV?

Do insiders & institutionals believe in MOH or ELV?

Which has better valuation and earnings, MOH or ELV?

Does the media prefer MOH or ELV?

Is MOH or ELV more profitable?

Summary

How does Elevance Health compare to UnitedHealth Group?

Is ELV or UNH a better dividend stock?

Which has stronger earnings & valuation, ELV or UNH?

Which has more risk & volatility, ELV or UNH?

Do institutionals & insiders hold more shares of ELV or UNH?

Do analysts rate ELV or UNH?

Does the media refer more to ELV or UNH?

Is ELV or UNH more profitable?

Summary

How does Elevance Health compare to Cigna Group?

Do analysts prefer ELV or CI?

Which has more volatility and risk, ELV or CI?

Does the media favor ELV or CI?

Is ELV or CI a better dividend stock?

Is ELV or CI more profitable?

Do institutionals and insiders believe in ELV or CI?

Which has higher valuation and earnings, ELV or CI?

Summary

How does Elevance Health compare to Humana?

Does the media prefer ELV or HUM?

Is ELV or HUM more profitable?

Which has more volatility and risk, ELV or HUM?

Which has stronger valuation & earnings, ELV or HUM?

Do insiders & institutionals have more ownership in ELV or HUM?

Is ELV or HUM a better dividend stock?

Do analysts rate ELV or HUM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELV vs. The Competition

Elevance Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools